Thematic Exposure -- 5/10
Altria is a textbook oligopolist in its core market -- but that core market (US combustible cigarettes)
is the structurally declining ~88% of its revenue, while the growing nicotine themes (oral pouches,
e-vapor) are exactly where MO is sub-scale and losing share. The oligopoly hard gate is cleared by
smokeable (Marlboro ~40.5% of US cigarettes, ~59.3% of premium), but the thematic-growth ceiling caps
the score: dominant in a flat-to-declining theme, minor in the growing ones. The 5/10 anchor applies.
Weight: 35%
Marlboro Cigarette Oligopoly -- Dominant but Declining
Oligopoly Gate: PASS -- but a declining theme
Marlboro is the single most dominant CPG brand in US cigarettes -- ~40.5% of the total category,
larger than the next ~10 brands combined, and ~59.3% of premium. The US cigarette market is a true
3-player oligopoly (PM USA/Altria ~45%, Reynolds/BAT, ITG Brands), protected by the 1998 Master
Settlement Agreement, FDA pre-market barriers, and decades of brand equity. MO is unambiguously a
price-setter: FY25 smokeable net pricing +8.4%, OCI margin 63.4% even as volume fell ~10%. Pricing
power, not unit growth, is the moat -- and the moat sits on a category that is going away.
Growth Themes -- Sub-Scale and Losing Share
Wrong Side of the Growth
The replacement is already happening: adult nicotine consumers migrate to oral pouches (~24% CAGR)
and e-vapor. In these growth themes MO is weak. on! holds only ~8.7% of total US oral and is
losing pouch share (~15.6%, -4.1pp) to PMI's ZYN, which dominates. NJOY is a distant e-vapor
also-ran (~2.5%) and was impaired $1.3B in Q4'25. MO owns the leadership of the declining theme
and is a minor player in the growing ones -- the exact inverse of what the 7-10 band rewards.
Segment Mix -- ~88% in the Declining Core
Concentration in a Shrinking Pool
Total net revenues fell $24,483M (FY23) to $24,018M (FY24) to $23,279M (FY25) -- a ~-2.5%/yr drift
driven by smokeable volume erosion only partly offset by pricing. Smokeable itself stepped down
$21,756M to $21,204M to $20,485M. Oral (~12%) is the only growth engine, but at ~$2.8B it is too
small and share-losing to lift the weighted thematic picture. The growth optionality (on! PLUS
national launch) is not yet large enough or share-winning enough.
Segment Share / TAM / Theme
| Segment | % Rev | Market Share | Theme Growth |
|---|---|---|---|
| Smokeable | ~88% | Marlboro ~40.5% total / ~59.3% premium; PM USA ~45.2% | Declining (volume ~-10%/yr; $ roughly flat via pricing) |
| Oral Tobacco | ~12% | ~8.7% total US oral; on! ~15.6% of pouch (-4.1pp) | Growing fast (~24% CAGR), but MO under-indexed |
| E-vapor (NJOY) | ~0% | NJOY ~2.5% (Vuse ~42%, JUUL ~24% lead) | Growing category; MO sub-scale, impaired $1.3B |
Oligopoly Gate
| Criterion | Result |
|---|---|
| Marlboro share of US cigarettes | ~40.5% |
| Any segment >30% share? | Yes (smokeable, ~88% of rev) |
| Structure (≤3 players >70%?) | Yes -- PM USA, Reynolds/BAT, ITG |
| Gate result | PASS |
5/10 — The oligopoly gate passes
decisively on Marlboro's ~40.5% share and price-setting power in a textbook 3-player US cigarette
oligopoly. But thematic exposure scores on where the growth is, and here MO is on the wrong side:
~88% of revenue sits in a category declining ~10%/yr, while the growing themes (pouches ~24% CAGR,
e-vapor) are precisely where MO is under-scaled and losing share. The 7-8 band requires a growing
theme plus advantages; MO has the advantages but not the growing theme in its dominant segment. The
9-10 band (theme growing >10%) fails outright. Dominant in a flat-to-declining theme -- the 5 anchor.
Data sourced from Daloopa (company_id 261).